These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

90 related items for PubMed ID: 8460404

  • 1. The role of CA 125 and conventional examinations in diagnosing progressive carcinoma of the ovary.
    van der Burg ME, Lammes FB, Verweij J.
    Surg Gynecol Obstet; 1993 Apr; 176(4):310-4. PubMed ID: 8460404
    [Abstract] [Full Text] [Related]

  • 2. Relationship of serum CA125 and lipid-associated sialic acid tumor-associated antigen levels to the disease status of patients with gynecologic malignancies.
    Stratton JA, Rettenmaier MA, Phillips HB, Herabutya S, DiSaia PJ.
    Obstet Gynecol; 1988 Jan; 71(1):20-6. PubMed ID: 2827081
    [Abstract] [Full Text] [Related]

  • 3. Role of Ca 125 as tumor marker in ovarian carcinoma.
    Krebs HB, Goplerud DR, Kilpatrick SJ, Myers MB, Hunt A.
    Obstet Gynecol; 1986 Apr; 67(4):473-7. PubMed ID: 3008052
    [Abstract] [Full Text] [Related]

  • 4. CA 125 in ovarian cancer.
    van der Burg ME, Lammes FB, Verweij J.
    Neth J Med; 1992 Feb; 40(1-2):36-51. PubMed ID: 1579185
    [Abstract] [Full Text] [Related]

  • 5. [Evaluation on non invasive diagnostic tests for the second look in epithelial ovarian cancer].
    García Enguídanos A, Crespo Azanza E, Díaz Recaséns J, Lobo Samper F, Jorge Herrero JA, Sáinz de la Cuesta Abbad R.
    Rev Clin Esp; 1998 Aug; 198(8):502-5. PubMed ID: 9774878
    [Abstract] [Full Text] [Related]

  • 6. Abdominal recurrence of ovarian cancer: value of abdominal MR in patients with positive CA125 and negative CT.
    Balestreri L, Bison L, Sorio R, Morra A, Campagnutta E, Morassut S.
    Radiol Med; 2002 Aug; 104(5-6):426-36. PubMed ID: 12589264
    [Abstract] [Full Text] [Related]

  • 7. [Clinical significance of galactosyltransferase associated with tumor (GAT), a new tumor marker for ovarian cancer--with special reference to the discrimination between ovarian cancer and endometriosis].
    Nozawa S, Udagawa Y, Ito K, Nishimura H, Yakushiji M, Shiota M, Noda K, Yajima M, Ohkura H, Murae M.
    Gan To Kagaku Ryoho; 1994 Mar; 21(4):507-16. PubMed ID: 8129392
    [Abstract] [Full Text] [Related]

  • 8. [Clinical usefulness of the combination assay of CA 125, SLX, and CA 72-4 in patients with ovarian cancer].
    Kobayashi H, Kawashima Y.
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Nov; 41(11):1731-5. PubMed ID: 2574209
    [Abstract] [Full Text] [Related]

  • 9. Serum CA 125, carcinoembryonic antigen, and CA 19-9 as tumor markers in borderline ovarian tumors.
    Engelen MJ, de Bruijn HW, Hollema H, ten Hoor KA, Willemse PH, Aalders JG, van der Zee AG.
    Gynecol Oncol; 2000 Jul; 78(1):16-20. PubMed ID: 10873403
    [Abstract] [Full Text] [Related]

  • 10. [Prospects of the use of neoplasm antigens as markers of gynecologic diseases].
    Adamian LV, Fanchenko ND, Andreeva EN, Novikov EA, Alekseeva ML.
    Sov Med; 1990 Jul; (6):26-9. PubMed ID: 2204116
    [Abstract] [Full Text] [Related]

  • 11. [Value of biological markers in the diagnosis and monitoring of cystadenocarcinoma].
    Bidart JM, Bellet D.
    Rev Prat; 1989 Nov 11; 39(26):2317-20. PubMed ID: 2595221
    [Abstract] [Full Text] [Related]

  • 12. An early signal of CA-125 progression for ovarian cancer patients receiving maintenance treatment after complete clinical response to primary therapy.
    Liu PY, Alberts DS, Monk BJ, Brady M, Moon J, Markman M.
    J Clin Oncol; 2007 Aug 20; 25(24):3615-20. PubMed ID: 17704410
    [Abstract] [Full Text] [Related]

  • 13. [Ovarian carcinoma antigen (CA 125) and ovarian cancer (clinical follow-up and prognostic studies)].
    Göcze P, Vahrson H.
    Orv Hetil; 1993 Apr 25; 134(17):915-8. PubMed ID: 8479736
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Prognostic value of CA 125 initial half-life measured during first-line chemotherapy in 62 patients with epithelial ovarian cancer stage III or IV].
    Riedinger JM, Barillot I, Coudert B, Fargeot P, Berriolo-Riedinger A, Guerrin J.
    Bull Cancer; 1996 Aug 25; 83(8):654-63. PubMed ID: 8869046
    [Abstract] [Full Text] [Related]

  • 20. The role of serum CA-125 levels in early-stage epithelial ovarian cancer on preoperative CT and MRI.
    Kim HS, Kim JW, Cho JY, Chung HH, Park NH, Song YS, Kim SH, Kang SB.
    Eur J Surg Oncol; 2009 Aug 25; 35(8):870-6. PubMed ID: 19179039
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.